Ariel Hammerman
Tel Aviv University(IL)Teva Pharmaceuticals (Israel)(IL)
Publications by Year
Research Areas
Diabetes Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Pharmaceutical Economics and Policy, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge(2022)356 cited
- → Real-world effectiveness of a single dose of mpox vaccine in males(2023)200 cited
- → Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study(2023)149 cited
- → Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years(2022)147 cited
- → Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization(2010)114 cited
- → Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data(2017)103 cited